() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Options

LGC Capital grants stock options

LGC Capital Ltd. (the "Corporation" or "LGC") (TSXV: LG) (OTCQB: LGGCF) ("LGC") announces that it has granted stock options to purchase a total of 8,250,000 common shares of the Corporation to certain of its officers, employees and consultants.  All of these options are exercisable at a price of $0.10 per share.  The options have a term of five years and are subject in all respects to the terms of LGC's stock option plan and the requirements of the TSX Venture Exchange.
Read more

Lexaria Bioscience Issues Options

December 14, 2018 - Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces the following option award.
Read more

Group Ten Metals Completes Private Placement Financing

The Private Placement is subject to final TSX-V approval and shares are subject to a hold period of four months and one day from their date of issuance, under applicable Canadian securities law. The shares have not been, and will not be, registered under the U.S. Securities Act or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons, absent registration or any applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. Proceeds from the Private Placement are intended to be used toward eligible Canadian Exploration Expenses, within the meaning of the Income Tax Act (Canada), at the Company’s Ontario and Yukon projects.
Read more

Kalytera Therapeutics agent exercises greenshoe

Kalytera Therapeutics agent exercises greenshoe KALYTERA THERAPEUTICS, INC. ANNOUNCES EXERCISE OF OVER-ALLOTMENT OPTION In connection with Kalytera Therapeutics Inc.'s previously announced public offering of units of the company for aggregate gross proceeds of $4,297,260, Echelon Wealth Partners Inc., which acted as agent for and on behalf of the company in connection with the offering, has…
Read more
Get $50 in free trades.